{
    "abstract": "Background: Co-administration of vaccines in adolescents may improve coverage. We assessed co-administration of quadrivalent meningococcal serogroups A, C, W and Y tetanus toxoid-conjugate vaccine (MenACWY-TT), human papillomavirus 16/18 AS04-adjuvanted vaccine (AS04-HPV16/18) and tetanus-diphtheria-acellular pertussis vaccine (Tdap) in girls and young women. Methods: In this phase IIIb study (NCT01755689), 1300 healthy 9\u201325-year-old females were randomized (1:1:1:1:1) to receive: MenACWY-TT at month (M) 0 and AS04-HPV16/18 at M1, M2, M7; MenACWY-TT and AS04-HPV16/18 at M0 and AS04-HPV16/18 at M1, M6; AS04-HPV16/18 at M0, M1, M6; MenACWY-TT, Tdap and AS04-HPV16/18 at M0 and AS04-HPV16/18 at M1, M6; Tdap and AS04-HPV16/18 at M0 and AS04-HPV16/18 at M1, M6. Immunogenicity, safety and reactogenicity were evaluated. Results: Immunogenicity of MenACWY-TT and AS04-HPV16/18 when co-administered was non-inferior to that of the 2 vaccines given separately. Co-administration of MenACWY-TT, AS04-HPV16/18 and Tdap was non-inferior to MenACWY-TT administered alone or to Tdap co-administered with AS04-HPV16/18 in terms of immunogenicity for all vaccine components, except pertussis antigens. Post-vaccination, \u226589.5% of participants reached antibody levels above the pre-specified threshold for all antigens. No safety concerns were identified. Conclusion: Our data support co-administration of MenACWY-TT with Tdap and AS04-HPV16/18 vaccines in adolescents.",
    "author_highlights": [
        {
            "endOffset": 22109,
            "sentence": "MenACWY-TT, AS04-HPV16/18 and Tdap were (co-)administered in 9\u201325-year-old females.",
            "startOffset": 22026
        },
        {
            "endOffset": 22196,
            "sentence": "Co-administration of the 3 vaccines was non-inferior to MenACWY-TT administered alone.",
            "startOffset": 22110
        },
        {
            "endOffset": 22304,
            "sentence": "For all antigens, \u226589.5% of participants reached post-vaccination antibody levels \u2265 pre-specified cut-offs.",
            "startOffset": 22197
        },
        {
            "endOffset": 22384,
            "sentence": "Co-administration of MenACWY-TT with Tdap and AS04-HPV16/18 was well-tolerated.",
            "startOffset": 22305
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Rabab Z.",
                    "initial": "R.Z.",
                    "last": "Jafri"
                },
                {
                    "first": "Asad",
                    "initial": "A.",
                    "last": "Ali"
                },
                {
                    "first": "Nancy E.",
                    "initial": "N.E.",
                    "last": "Messonnier"
                },
                {
                    "first": "Carol",
                    "initial": "C.",
                    "last": "Tevi-Benissan"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Durrheim"
                },
                {
                    "first": "Juhani",
                    "initial": "J.",
                    "last": "Eskola"
                },
                {
                    "first": "Florence",
                    "initial": "F.",
                    "last": "Fermon"
                },
                {
                    "first": "Keith P.",
                    "initial": "K.P.",
                    "last": "Klugman"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Ramsay"
                },
                {
                    "first": "Samba",
                    "initial": "S.",
                    "last": "Sow"
                },
                {
                    "first": "Shao",
                    "initial": "S.",
                    "last": "Zhujun"
                },
                {
                    "first": "Zulfiqar A.",
                    "initial": "Z.A.",
                    "last": "Bhutta"
                },
                {
                    "first": "Jon",
                    "initial": "J.",
                    "last": "Abramson"
                }
            ],
            "doi": "10.1186/1478-7954-11-17",
            "issn": "14787954",
            "pub_year": 2013,
            "title": "Global epidemiology of invasive meningococcal disease",
            "volume": "11"
        },
        "b0010": {
            "authors": [
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Gabutti"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Stefanati"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Kuhdari"
                }
            ],
            "firstpage": "E116",
            "issn": "11212233",
            "lastpage": "E120",
            "pub_year": 2015,
            "title": "Epidemiology of Neisseria meningitidis infections: Case distribution by age and relevance of carriage",
            "volume": "56"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                },
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Ramsay"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.04.063",
            "firstpage": "B51",
            "issn": "0264410X",
            "lastpage": "B63",
            "pmid": "19477562",
            "pub_year": 2009,
            "title": "Global epidemiology of meningococcal disease",
            "volume": "27"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Stephen I.",
                    "initial": "S.I.",
                    "last": "Pelton"
                }
            ],
            "doi": "10.1016/j.jadohealth.2016.04.012",
            "firstpage": "S3",
            "issn": "1054139X",
            "lastpage": "S11",
            "pmid": "27449148",
            "pub_year": 2016,
            "title": "The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines",
            "volume": "59"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Marco Aur\u00e9lio P.",
                    "initial": "M.A.P.",
                    "last": "S\u00e1fadi"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "O'Ryan"
                },
                {
                    "first": "Maria Teresa",
                    "initial": "M.T.",
                    "last": "Valenzuela Bravo"
                },
                {
                    "first": "Maria Cristina C.",
                    "initial": "M.C.C.",
                    "last": "Brandileone"
                },
                {
                    "first": "Maria Cec\u00edlia O.",
                    "initial": "M.C.O.",
                    "last": "Gorla"
                },
                {
                    "first": "Ana Paula S.",
                    "initial": "A.P.S.",
                    "last": "de Lemos"
                },
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Moreno"
                },
                {
                    "first": "Julio A.",
                    "initial": "J.A.",
                    "last": "Vazquez"
                },
                {
                    "first": "Eduardo L.",
                    "initial": "E.L.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.055",
            "firstpage": "6529",
            "issn": "0264410X",
            "lastpage": "6536",
            "pmid": "26597036",
            "pub_year": 2015,
            "title": "The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations",
            "volume": "33"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Whittaker"
                },
                {
                    "first": "Joana Gomes",
                    "initial": "J.G.",
                    "last": "Dias"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Ramliden"
                },
                {
                    "first": "Csaba",
                    "initial": "C.",
                    "last": "K\u00f6dm\u00f6n"
                },
                {
                    "first": "Assimoula",
                    "initial": "A.",
                    "last": "Economopoulou"
                },
                {
                    "first": "Netta",
                    "initial": "N.",
                    "last": "Beer"
                },
                {
                    "first": "Lucia",
                    "initial": "L.",
                    "last": "Pastore Celentano"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2017.03.007",
            "firstpage": "2034",
            "issn": "0264410X",
            "lastpage": "2041",
            "pmid": "28314560",
            "pub_year": 2017,
            "title": "The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004\u20132014",
            "volume": "35"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Mustapha M.",
                    "initial": "M.M.",
                    "last": "Mustapha"
                },
                {
                    "first": "Jane W.",
                    "initial": "J.W.",
                    "last": "Marsh"
                },
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.02.014",
            "firstpage": "1515",
            "issn": "0264410X",
            "lastpage": "1523",
            "pmid": "26876439",
            "pub_year": 2016,
            "title": "Global epidemiology of capsular group W meningococcal disease (1970-2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex",
            "volume": "34"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Christensen"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "May"
                },
                {
                    "first": "Leah",
                    "initial": "L.",
                    "last": "Bowen"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Hickman"
                },
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                }
            ],
            "doi": "10.1016/S1473-3099(10)70251-6",
            "firstpage": "853",
            "issn": "14733099",
            "lastpage": "861",
            "pmid": "21075057",
            "pub_year": 2010,
            "title": "Meningococcal carriage by age: A systematic review and meta-analysis",
            "volume": "10"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Merijn W.",
                    "initial": "M.W.",
                    "last": "Bijlsma"
                },
                {
                    "first": "Matthijs C.",
                    "initial": "M.C.",
                    "last": "Brouwer"
                },
                {
                    "first": "Lodewijk",
                    "initial": "L.",
                    "last": "Spanjaard"
                },
                {
                    "first": "Diederik Van De",
                    "initial": "D.V.D.",
                    "last": "Beek"
                },
                {
                    "first": "Arie Van Der",
                    "initial": "A.V.D.",
                    "last": "Ende"
                }
            ],
            "doi": "10.1093/cid/ciu601",
            "firstpage": "1216",
            "issn": "10584838",
            "lastpage": "1221",
            "pmid": "25069869",
            "pub_year": 2014,
            "title": "A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination",
            "volume": "59"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                },
                {
                    "first": "Martin C.J.",
                    "initial": "M.C.J.",
                    "last": "Maiden"
                }
            ],
            "doi": "10.1586/erv.09.48",
            "firstpage": "851",
            "issn": "14760584",
            "lastpage": "861",
            "pmid": "19538112",
            "pub_year": 2009,
            "title": "Meningococcal vaccines and herd immunity: Lessons learned from serogroup C conjugate vaccination programs",
            "volume": "8"
        },
        "b0055": null,
        "b0060": {
            "authors": [
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Tan"
                },
                {
                    "first": "Tine",
                    "initial": "T.",
                    "last": "Dalby"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Forsyth"
                },
                {
                    "first": "Scott A.",
                    "initial": "S.A.",
                    "last": "Halperin"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Hozbor"
                },
                {
                    "first": "Stanley",
                    "initial": "S.",
                    "last": "Plotkin"
                },
                {
                    "first": "Rolando",
                    "initial": "R.",
                    "last": "Ulloa-Gutierrez"
                },
                {
                    "first": "Carl Heinz Wirsing",
                    "initial": "C.H.W.",
                    "last": "Von K\u00f6nig"
                }
            ],
            "doi": "10.1097/INF.0000000000000795",
            "firstpage": "e222",
            "issn": "08913668",
            "lastpage": "e232",
            "pmid": "26376316",
            "pub_year": 2015,
            "title": "Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013",
            "volume": "34"
        },
        "b0065": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Esposito"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Principi"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.cmi.2016.01.003",
            "firstpage": "S89",
            "issn": "1198743X",
            "lastpage": "S95",
            "pmid": "27130670",
            "pub_year": 2016,
            "title": "Immunization against pertussis in adolescents and adults",
            "volume": "22"
        },
        "b0070": {
            "authors": [
                {
                    "first": "D. W.",
                    "initial": "D.W.",
                    "last": "Jackson"
                },
                {
                    "first": "Pejman",
                    "initial": "P.",
                    "last": "Rohani"
                }
            ],
            "doi": "10.1017/S0950268812003093",
            "firstpage": "672",
            "issn": "09502688",
            "lastpage": "684",
            "pmid": "23324361",
            "pub_year": 2014,
            "title": "Perplexities of pertussis: Recent global epidemiological trends and their potential causes",
            "volume": "142"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Bruni"
                },
                {
                    "first": "Mireia",
                    "initial": "M.",
                    "last": "Diaz"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Ferrer"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "De Sanjos\u00e9"
                }
            ],
            "doi": "10.1086/657321",
            "firstpage": "1789",
            "issn": "00221899",
            "lastpage": "1799",
            "pmid": "21067372",
            "pub_year": 2010,
            "title": "Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings",
            "volume": "202"
        },
        "b0080": {
            "authors": [],
            "firstpage": "241",
            "issn": "00498114",
            "lastpage": "268",
            "pmid": "28530369",
            "pub_year": 2017,
            "title": "Human papillomavirus vaccines: WHO position paper, May 2017",
            "volume": "92"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "de Sanjose"
                },
                {
                    "first": "Wim G.V.",
                    "initial": "W.G.V.",
                    "last": "Quint"
                },
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Alemany"
                },
                {
                    "first": "Daan T.",
                    "initial": "D.T.",
                    "last": "Geraets"
                },
                {
                    "first": "Jo Ellen",
                    "initial": "J.E.",
                    "last": "Klaustermeier"
                },
                {
                    "first": "Belen",
                    "initial": "B.",
                    "last": "Lloveras"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Tous"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Felix"
                },
                {
                    "first": "Luis Eduardo",
                    "initial": "L.E.",
                    "last": "Bravo"
                },
                {
                    "first": "Hai Rim",
                    "initial": "H.R.",
                    "last": "Shin"
                },
                {
                    "first": "Carlos S.",
                    "initial": "C.S.",
                    "last": "Vallejos"
                },
                {
                    "first": "Patricia Alonso",
                    "initial": "P.A.",
                    "last": "de Ruiz"
                },
                {
                    "first": "Marcus Aurelho",
                    "initial": "M.A.",
                    "last": "Lima"
                },
                {
                    "first": "Nuria",
                    "initial": "N.",
                    "last": "Guimera"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Clavero"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Alejo"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Llombart-Bosch"
                },
                {
                    "first": "Chou",
                    "initial": "C.",
                    "last": "Cheng-Yang"
                },
                {
                    "first": "Silvio Alejandro",
                    "initial": "S.A.",
                    "last": "Tatti"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Kasamatsu"
                },
                {
                    "first": "Ermina",
                    "initial": "E.",
                    "last": "Iljazovic"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Odida"
                },
                {
                    "first": "Rodrigo",
                    "initial": "R.",
                    "last": "Prado"
                },
                {
                    "first": "Muhieddine",
                    "initial": "M.",
                    "last": "Seoud"
                },
                {
                    "first": "Magdalena",
                    "initial": "M.",
                    "last": "Grce"
                },
                {
                    "first": "Alp",
                    "initial": "A.",
                    "last": "Usubutun"
                },
                {
                    "first": "Asha",
                    "initial": "A.",
                    "last": "Jain"
                },
                {
                    "first": "Gustavo Adolfo Hernandez",
                    "initial": "G.A.H.",
                    "last": "Suarez"
                },
                {
                    "first": "Luis Estuardo",
                    "initial": "L.E.",
                    "last": "Lombardi"
                },
                {
                    "first": "Aekunbiola",
                    "initial": "A.",
                    "last": "Banjo"
                },
                {
                    "first": "Clara",
                    "initial": "C.",
                    "last": "Men\u00e9ndez"
                },
                {
                    "first": "Efr\u00e9n Javier",
                    "initial": "E.J.",
                    "last": "Domingo"
                },
                {
                    "first": "Julio",
                    "initial": "J.",
                    "last": "Velasco"
                },
                {
                    "first": "Ashrafun",
                    "initial": "A.",
                    "last": "Nessa"
                },
                {
                    "first": "Saibua C.Bunnag",
                    "initial": "S.C.B.",
                    "last": "Chichareon"
                },
                {
                    "first": "You Lin",
                    "initial": "Y.L.",
                    "last": "Qiao"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Lerma"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Toshiyuki",
                    "initial": "T.",
                    "last": "Sasagawa"
                },
                {
                    "first": "Annabelle",
                    "initial": "A.",
                    "last": "Ferrera"
                },
                {
                    "first": "Doudja",
                    "initial": "D.",
                    "last": "Hammouda"
                },
                {
                    "first": "Luciano",
                    "initial": "L.",
                    "last": "Mariani"
                },
                {
                    "first": "Adela",
                    "initial": "A.",
                    "last": "Pelayo"
                },
                {
                    "first": "Ivo",
                    "initial": "I.",
                    "last": "Steiner"
                },
                {
                    "first": "Esther",
                    "initial": "E.",
                    "last": "Oliva"
                },
                {
                    "first": "Chris J.L.M.",
                    "initial": "C.J.L.M.",
                    "last": "Meijer"
                },
                {
                    "first": "Waleed Fahad",
                    "initial": "W.F.",
                    "last": "Al-Jassar"
                },
                {
                    "first": "Eugenia",
                    "initial": "E.",
                    "last": "Cruz"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Wright"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Puras"
                },
                {
                    "first": "Cecilia Ladines",
                    "initial": "C.L.",
                    "last": "Llave"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Tzardi"
                },
                {
                    "first": "Theodoros",
                    "initial": "T.",
                    "last": "Agorastos"
                },
                {
                    "first": "Victoria",
                    "initial": "V.",
                    "last": "Garcia-Barriola"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Clavel"
                },
                {
                    "first": "Jaume",
                    "initial": "J.",
                    "last": "Ordi"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "And\u00fajar"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Gloria I.",
                    "initial": "G.I.",
                    "last": "S\u00e1nchez"
                },
                {
                    "first": "Andrzej Marcin",
                    "initial": "A.M.",
                    "last": "Nowakowski"
                },
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "Bornstein"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                }
            ],
            "doi": "10.1016/S1470-2045(10)70230-8",
            "firstpage": "1048",
            "issn": "14702045",
            "lastpage": "1056",
            "pmid": "20952254",
            "pub_year": 2010,
            "title": "Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study",
            "volume": "11"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Lindsey A.",
                    "initial": "L.A.",
                    "last": "Torre"
                },
                {
                    "first": "Freddie",
                    "initial": "F.",
                    "last": "Bray"
                },
                {
                    "first": "Rebecca L.",
                    "initial": "R.L.",
                    "last": "Siegel"
                },
                {
                    "first": "Jacques",
                    "initial": "J.",
                    "last": "Ferlay"
                },
                {
                    "first": "Joannie",
                    "initial": "J.",
                    "last": "Lortet-Tieulent"
                },
                {
                    "first": "Ahmedin",
                    "initial": "A.",
                    "last": "Jemal"
                }
            ],
            "doi": "10.3322/caac.21262",
            "firstpage": "87",
            "issn": "00079235",
            "lastpage": "108",
            "pmid": "25651787",
            "pub_year": 2015,
            "title": "Global cancer statistics, 2012",
            "volume": "65"
        },
        "b0095": null,
        "b0100": {
            "authors": [
                {
                    "first": "Henry H.",
                    "initial": "H.H.",
                    "last": "Bernstein"
                },
                {
                    "first": "Joseph A.",
                    "initial": "J.A.",
                    "last": "Bocchini"
                },
                {
                    "first": "Carrie L.",
                    "initial": "C.L.",
                    "last": "Byington"
                },
                {
                    "first": "Yvonne A.",
                    "initial": "Y.A.",
                    "last": "Maldonado"
                },
                {
                    "first": "Elizabeth D.",
                    "initial": "E.D.",
                    "last": "Barnett"
                },
                {
                    "first": "James D.",
                    "initial": "J.D.",
                    "last": "Campbell"
                },
                {
                    "first": "H. Dele",
                    "initial": "H.D.",
                    "last": "Davies"
                },
                {
                    "first": "Ruth",
                    "initial": "R.",
                    "last": "Lynfield"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Bratic"
                },
                {
                    "first": "Flor M.",
                    "initial": "F.M.",
                    "last": "Munoz"
                },
                {
                    "first": "Dawn",
                    "initial": "D.",
                    "last": "Nolt"
                },
                {
                    "first": "Ann Christine",
                    "initial": "A.C.",
                    "last": "Nyquist"
                },
                {
                    "first": "Sean",
                    "initial": "S.",
                    "last": "O'Leary"
                },
                {
                    "first": "Mobeen H.",
                    "initial": "M.H.",
                    "last": "Rathore"
                },
                {
                    "first": "Mark H.",
                    "initial": "M.H.",
                    "last": "Sawyer"
                },
                {
                    "first": "William J.",
                    "initial": "W.J.",
                    "last": "Steinbach"
                },
                {
                    "first": "Tina Q.",
                    "initial": "T.Q.",
                    "last": "Tan"
                },
                {
                    "first": "Theoklis E.",
                    "initial": "T.E.",
                    "last": "Zaoutis"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1542/peds.2016-4186",
            "issn": "00314005",
            "pmid": "28167517",
            "pub_year": 2017,
            "title": "The need to optimize adolescent immunization",
            "volume": "139"
        },
        "b0105": {
            "authors": [
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Gallagher"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Kadokura"
                },
                {
                    "first": "L. O.",
                    "initial": "L.O.",
                    "last": "Eckert"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Miyake"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Mounier-Jack"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Aldea"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Ross"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Watson-Jones"
                }
            ],
            "doi": "10.1186/s12889-016-2845-z",
            "issn": "14712458",
            "pmid": "26895838",
            "pub_year": 2016,
            "title": "Factors influencing completion of multi-dose vaccine schedules in adolescents: A systematic review",
            "volume": "16"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Sharon J.M.",
                    "initial": "S.J.M.",
                    "last": "Kessels"
                },
                {
                    "first": "Helen S.",
                    "initial": "H.S.",
                    "last": "Marshall"
                },
                {
                    "first": "Maureen",
                    "initial": "M.",
                    "last": "Watson"
                },
                {
                    "first": "Annette J.",
                    "initial": "A.J.",
                    "last": "Braunack-Mayer"
                },
                {
                    "first": "Rob",
                    "initial": "R.",
                    "last": "Reuzel"
                },
                {
                    "first": "Rebecca L.",
                    "initial": "R.L.",
                    "last": "Tooher"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.03.063",
            "firstpage": "3546",
            "issn": "0264410X",
            "lastpage": "3556",
            "pmid": "22480928",
            "pub_year": 2012,
            "title": "Factors associated with HPV vaccine uptake in teenage girls: A systematic review",
            "volume": "30"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Crum-Cianflone"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Sullivan"
                }
            ],
            "doi": "10.1007/s40121-016-0107-0",
            "firstpage": "89",
            "issn": "21938229",
            "lastpage": "112",
            "pub_year": 2016,
            "title": "Meningococcal Vaccinations",
            "volume": "5"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Aia",
                    "initial": "A.",
                    "last": "Assaf-Casals"
                },
                {
                    "first": "Ghassan",
                    "initial": "G.",
                    "last": "Dbaibo"
                }
            ],
            "doi": "10.1080/21645515.2016.1143157",
            "firstpage": "1825",
            "issn": "21645515",
            "lastpage": "1837",
            "pmid": "26900984",
            "pub_year": 2016,
            "title": "Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix\u2122): A review of its immunogenicity, safety, co-administration, and antibody persistence",
            "volume": "12"
        },
        "b0125": null,
        "b0130": null,
        "b0135": null,
        "b0140": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Leonardi"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Latiolais"
                },
                {
                    "first": "Kwabena",
                    "initial": "K.",
                    "last": "Sarpong"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Simon"
                },
                {
                    "first": "Jerry",
                    "initial": "J.",
                    "last": "Twiggs"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Lei"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Rinderknecht"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Blatter"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Leonard R.",
                    "initial": "L.R.",
                    "last": "Friedland"
                },
                {
                    "first": "Carmen",
                    "initial": "C.",
                    "last": "Baccarini"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.09.064",
            "firstpage": "924",
            "issn": "0264410X",
            "lastpage": "932",
            "pmid": "25305567",
            "pub_year": 2015,
            "title": "Immunogenicity and reactogenicity of Infanrix\u2122 when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix\u2122 and Pediarix\u2122",
            "volume": "33"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Jos\u00e9",
                    "initial": "J.",
                    "last": "Garcia-Sicilia"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Alfonso",
                    "initial": "A.",
                    "last": "Carmona"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Peters"
                },
                {
                    "first": "Jean Elie",
                    "initial": "J.E.",
                    "last": "Malkin"
                },
                {
                    "first": "Phu M.",
                    "initial": "P.M.",
                    "last": "Tran"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Behre"
                },
                {
                    "first": "Enrique B.",
                    "initial": "E.B.",
                    "last": "Iturbe"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Catteau"
                },
                {
                    "first": "Florence",
                    "initial": "F.",
                    "last": "Thomas"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Dobbelaere"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Descamps"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Dubin"
                }
            ],
            "doi": "10.1016/j.jadohealth.2009.11.205",
            "firstpage": "142",
            "issn": "1054139X",
            "lastpage": "151",
            "pub_year": 2010,
            "title": "Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis-inactivated Poliovirus Vaccine to Girls and Young Women",
            "volume": "46"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1128/CDLI.10.5.780-786.2003",
            "firstpage": "780",
            "issn": "1071412X",
            "lastpage": "786",
            "pmid": "12965904",
            "pub_year": 2003,
            "title": "Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England",
            "volume": "10"
        },
        "b0155": null,
        "b0160": {
            "authors": [
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Balmer"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.01.051",
            "firstpage": "2222",
            "issn": "0264410X",
            "lastpage": "2227",
            "pmid": "15755600",
            "pub_year": 2005,
            "title": "Meningococcal surrogates of protection - Serum bactericidal antibody activity",
            "volume": "23"
        },
        "b0165": {
            "authors": [
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Camargo"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Silveira"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Furuta"
                },
                {
                    "first": "E. P.",
                    "initial": "E.P.",
                    "last": "Oliveira"
                },
                {
                    "first": "O. A.",
                    "initial": "O.A.",
                    "last": "Germek"
                }
            ],
            "doi": "10.1128/jcm.20.4.772-774.1984",
            "firstpage": "772",
            "issn": "00951137",
            "lastpage": "774",
            "pmid": "6386879",
            "pub_year": 1984,
            "title": "Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum",
            "volume": "20"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Moira E.",
                    "initial": "M.E.",
                    "last": "Melville-Smith"
                },
                {
                    "first": "Valerie A.",
                    "initial": "V.A.",
                    "last": "Seagroatt"
                },
                {
                    "first": "Johanna T.",
                    "initial": "J.T.",
                    "last": "Watkins"
                }
            ],
            "doi": "10.1016/S0092-1157(83)80038-9",
            "firstpage": "137",
            "issn": "00921157",
            "lastpage": "144",
            "pmid": "6345548",
            "pub_year": 1983,
            "title": "A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera",
            "volume": "11"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Stanley A.",
                    "initial": "S.A.",
                    "last": "Plotkin"
                }
            ],
            "doi": "10.1128/CVI.00131-10",
            "firstpage": "1055",
            "issn": "15566811",
            "lastpage": "1065",
            "pmid": "20463105",
            "pub_year": 2010,
            "title": "Correlates of protection induced by vaccination",
            "volume": "17"
        },
        "b0180": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Granstr\u00f6m"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Thor\u00e9n"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Blennow"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Tiru"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Sato"
                }
            ],
            "doi": "10.1007/BF02097184",
            "firstpage": "18",
            "issn": "07222211",
            "lastpage": "21",
            "pmid": "2883004",
            "pub_year": 1987,
            "title": "Acellular pertussis vaccine in adults: Adverse reactions and immune response",
            "volume": "6"
        },
        "b0185": {
            "authors": [
                {
                    "first": "K. F.",
                    "initial": "K.F.",
                    "last": "Karpinski"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Hayward"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Tryphonas"
                }
            ],
            "doi": "10.1016/0022-1759(87)90289-4",
            "firstpage": "189",
            "issn": "00221759",
            "lastpage": "194",
            "pmid": "3668258",
            "pub_year": 1987,
            "title": "Statistical considerations in the quantitation of serum immunoglobulin levels using the Enzyme-Linked Immunosorbent Assay (ELISA)",
            "volume": "103"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Charissa",
                    "initial": "C.",
                    "last": "Borja-Tabora"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Montalban"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1186/1471-2334-13-116",
            "issn": "14712334",
            "pmid": "23510357",
            "pub_year": 2013,
            "title": "Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: Results of an open, randomised, controlled study",
            "volume": "13"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "\u00d8stergaard"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Lebacq"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Gudrun",
                    "initial": "G.",
                    "last": "Maechler"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.08.075",
            "firstpage": "161",
            "issn": "0264410X",
            "lastpage": "168",
            "pmid": "18834910",
            "pub_year": 2009,
            "title": "Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years",
            "volume": "27"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Mari\u00ebtte B.",
                    "initial": "M.B.",
                    "last": "van Ravenhorst"
                },
                {
                    "first": "Fiona R.M.",
                    "initial": "F.R.M.",
                    "last": "van der Klis"
                },
                {
                    "first": "Debbie M.",
                    "initial": "D.M.",
                    "last": "van Rooijen"
                },
                {
                    "first": "Elisabeth A.M.",
                    "initial": "E.A.M.",
                    "last": "Sanders"
                },
                {
                    "first": "Guy A.M.",
                    "initial": "G.A.M.",
                    "last": "Berbers"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.06.007",
            "firstpage": "4753",
            "issn": "0264410X",
            "lastpage": "4760",
            "pmid": "28647167",
            "pub_year": 2017,
            "title": "Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination",
            "volume": "35"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Rivera"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Kyung Hyo",
                    "initial": "K.H.",
                    "last": "Kim"
                },
                {
                    "first": "Yun Kyung",
                    "initial": "Y.K.",
                    "last": "Kim"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Behre"
                },
                {
                    "first": "Sung Ho",
                    "initial": "S.H.",
                    "last": "Cha"
                },
                {
                    "first": "Dae Sun",
                    "initial": "D.S.",
                    "last": "Jo"
                },
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "Lee"
                },
                {
                    "first": "Jin Soo",
                    "initial": "J.S.",
                    "last": "Lee"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Cheuvart"
                },
                {
                    "first": "Archana",
                    "initial": "A.",
                    "last": "Jastorff"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                }
            ],
            "doi": "10.1016/j.vaccine.2018.04.034",
            "firstpage": "4750",
            "issn": "0264410X",
            "lastpage": "4758",
            "pmid": "29960800",
            "pub_year": 2018,
            "title": "Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study",
            "volume": "36"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Charissa Fay Corazon",
                    "initial": "C.F.C.",
                    "last": "Borja-Tabora"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Montalban"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                },
                {
                    "first": "Devayani",
                    "initial": "D.",
                    "last": "Kolhe"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                }
            ],
            "doi": "10.1186/s12879-015-1138-y",
            "issn": "14712334",
            "pmid": "26437712",
            "pub_year": 2015,
            "title": "Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial",
            "volume": "15"
        },
        "b0220": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Findlow"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1080/21645515.2015.1091908",
            "firstpage": "226",
            "issn": "21645515",
            "lastpage": "230",
            "pmid": "26619353",
            "pub_year": 2016,
            "title": "Interactions of conjugate vaccines and co-administered vaccines",
            "volume": "12"
        },
        "b0225": null,
        "b0230": {
            "authors": [
                {
                    "first": "Wayde M.",
                    "initial": "W.M.",
                    "last": "Weston"
                },
                {
                    "first": "Leonard R.",
                    "initial": "L.R.",
                    "last": "Friedland"
                },
                {
                    "first": "Xiangfeng",
                    "initial": "X.",
                    "last": "Wu"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Howe"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.11.057",
            "firstpage": "1017",
            "issn": "0264410X",
            "lastpage": "1022",
            "pmid": "21134450",
            "pub_year": 2011,
            "title": "Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration",
            "volume": "29"
        },
        "b0235": {
            "authors": [
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Schmitt"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Schuind"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Beutel"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Schulte-Wissermann"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Gahr"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schult"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Folkens"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Rauh"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Bogaerts"
                },
                {
                    "first": "H. L.",
                    "initial": "H.L.",
                    "last": "Bork"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Clemens"
                }
            ],
            "doi": "10.1016/S0022-3476(96)70152-X",
            "firstpage": "695",
            "issn": "00223476",
            "lastpage": "701",
            "pmid": "8917236",
            "pub_year": 1996,
            "title": "Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants",
            "volume": "129"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Booy"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Van Der Meeren"
                },
                {
                    "first": "Su Peing",
                    "initial": "S.P.",
                    "last": "Ng"
                },
                {
                    "first": "Froilan",
                    "initial": "F.",
                    "last": "Celzo"
                },
                {
                    "first": "Gunasekaran",
                    "initial": "G.",
                    "last": "Ramakrishnan"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Jacquet"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.10.025",
            "firstpage": "45",
            "issn": "0264410X",
            "lastpage": "50",
            "pmid": "20974302",
            "pub_year": 2010,
            "title": "A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix\u2122) is immunogenic and well tolerated in adults",
            "volume": "29"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                },
                {
                    "first": "Mark M.",
                    "initial": "M.M.",
                    "last": "Blatter"
                },
                {
                    "first": "William A.",
                    "initial": "W.A.",
                    "last": "Kennedy"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Hedrick"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Descamps"
                },
                {
                    "first": "Leonard R.",
                    "initial": "L.R.",
                    "last": "Friedland"
                }
            ],
            "doi": "10.1542/peds.2005-1759",
            "firstpage": "1084",
            "issn": "00314005",
            "lastpage": "1093",
            "pmid": "16585302",
            "pub_year": 2006,
            "title": "Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents",
            "volume": "117"
        },
        "b0250": {
            "authors": [
                {
                    "first": "Heinz J.",
                    "initial": "H.J.",
                    "last": "Schmitt"
                },
                {
                    "first": "Carl H.Wirsing",
                    "initial": "C.H.W.",
                    "last": "Von K\u00f6nig"
                },
                {
                    "first": "Albrecht",
                    "initial": "A.",
                    "last": "Neiss"
                },
                {
                    "first": "Hugues",
                    "initial": "H.",
                    "last": "Bogaerts"
                },
                {
                    "first": "Hans L.",
                    "initial": "H.L.",
                    "last": "Bock"
                },
                {
                    "first": "Hermann",
                    "initial": "H.",
                    "last": "Schulte-Wissermann"
                },
                {
                    "first": "Manfred",
                    "initial": "M.",
                    "last": "Gahr"
                },
                {
                    "first": "Rainer",
                    "initial": "R.",
                    "last": "Schult"
                },
                {
                    "first": "Jens U.",
                    "initial": "J.U.",
                    "last": "Folkens"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Rauh"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Clemens"
                }
            ],
            "doi": "10.1001/jama.275.1.37",
            "firstpage": "37",
            "issn": "00987484",
            "lastpage": "41",
            "pmid": "8531284",
            "pub_year": 1996,
            "title": "Efficacy of acellular pertussis vaccine in early childhood after household exposure",
            "volume": "275"
        }
    },
    "body_text": [
        {
            "endOffset": 38361,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "For the 21 pregnancies reported (of which three were still ongoing at study end), no cases of congenital anomalies were noted and 13 pregnancies led to the birth of a live infant.",
            "startOffset": 38182,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 37100,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Grade 3 reactions were reported by \u22642.7, \u22648.1 and \u22648.8% of participants after one dose of MenACWY-TT, Tdap and AS04-HPV16/18, respectively (Fig. 2A).",
            "startOffset": 36951,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 36562,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "For pertussis antigens, the percentage of participants with antibody concentration above the assay cut-offs was \u226598.0% in groups Co-ad and Tdap; antibody GMCs were lower in the Co-ad group compared with the Tdap group (Table 4).",
            "startOffset": 36334,
            "title": "Tdap"
        },
        {
            "endOffset": 44884,
            "parents": [],
            "secId": "s0070",
            "sentence": "The study was well-controlled in terms of immunogenicity after co-administration and demonstrated high compliance and low drop-out rates and our results warrant further persistence studies to evaluate the long-term immune response induced by co-administration of the three vaccines.",
            "startOffset": 44602,
            "title": "Discussion"
        },
        {
            "endOffset": 29913,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Written informed assent for participants under the legal age was collected according to local regulations in each country.",
            "startOffset": 29791,
            "title": "Study design and participants"
        },
        {
            "endOffset": 40745,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 40744,
                    "startOffset": 40740
                }
            },
            "secId": "s0070",
            "sentence": "Immunogenicity of AS04-HPV16/18 when co-administered with either MenACWY-TT or MenACWY-TT and Tdap was comparable to that of the vaccine administered alone, in line with previous results reporting on co-administration with Tdap in girls and young women [29].",
            "startOffset": 40487,
            "title": "Discussion"
        },
        {
            "endOffset": 29234,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All vaccines (described in Text S2) were administered intramuscularly as 0.5 mL doses, into the right (MenACWY-TT) or left (AS04-HPV16/18) deltoid.",
            "startOffset": 29087,
            "title": "Study design and participants"
        },
        {
            "endOffset": 46417,
            "parents": [],
            "secId": "s0085",
            "sentence": "All authors had full access to the data and had final responsibility to submit for publication.",
            "startOffset": 46322,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 30845,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Approximately seven millilitres of blood were collected from each participant.",
            "startOffset": 30767,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33817,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "GMTs/GMCs were calculated by taking the anti-log of the mean of the log10 titre/concentration transformations; concentrations/titres below the cut-off of the assay were given an arbitrary value of half the cut-off.",
            "startOffset": 33603,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 40144,
            "parents": [],
            "secId": "s0070",
            "sentence": "For all groups in our study, rSBA GMT increases for serogroup A were lower than for C, W and Y at one month post-vaccination.",
            "startOffset": 40019,
            "title": "Discussion"
        },
        {
            "endOffset": 43910,
            "parents": [],
            "secId": "s0070",
            "sentence": "Meningococcal vaccination is not included in the immunization schedule for the targeted age groups in any of the countries in which the study was conducted.",
            "startOffset": 43754,
            "title": "Discussion"
        },
        {
            "endOffset": 32071,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0180": {
                    "endOffset": 31896,
                    "startOffset": 31889
                },
                "b0185": {
                    "endOffset": 31896,
                    "startOffset": 31889
                }
            },
            "secId": "s0020",
            "sentence": "Immune responses to pertussis components were measured by an in-house ELISA [36,37], with assay cut-offs of 2.693 IU/ml for anti-pertussis toxoid (PT), 2.046 IU/ml for anti- filamentous hemagglutinin (FHA) and 2.187 IU/ml for anti-pertactin (PRN) antibodies.",
            "startOffset": 31813,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 35252,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0055",
            "sentence": "Non-inferiority of AS04-HPV16/18 co-administered with MenACWY-TT compared to AS04-HPV16/18 alone or with MenACWY-TT and Tdap compared to AS04-HPV16/18 and Tdap was demonstrated (Table 1).",
            "startOffset": 35065,
            "title": "AS04-HPV16/18"
        },
        {
            "endOffset": 35911,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "Non-inferiority criteria for the immunogenicity of Tdap co-administered with MenACWY-TT and AS04-HPV16/18 compared to Tdap co-administered with AS04-HPV16/18 were met for diphtheria and tetanus, but not for the pertussis antigens; hence the sixth co-primary objective was not met (Table 1).",
            "startOffset": 35621,
            "title": "Tdap"
        },
        {
            "endOffset": 39714,
            "parents": [],
            "secId": "s0070",
            "sentence": "Higher GMTs were observed for all serogroups in the ACWYHPV and ACWY groups compared with the Co-ad group, although the immune response to MenACWY-TT in the Co-ad group was non-inferior to that in the ACWY group.",
            "startOffset": 39502,
            "title": "Discussion"
        },
        {
            "endOffset": 35424,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0055",
            "sentence": "One month after the third AS04-HPV16/18 dose, the percentage of participants with anti-HPV antibody concentrations \u2265pre-specified thresholds was \u226599.6% in each study group.",
            "startOffset": 35252,
            "title": "AS04-HPV16/18"
        },
        {
            "endOffset": 44992,
            "parents": [],
            "secId": "s0070",
            "sentence": "The study limitations include the stringent criteria used to define non-inferiority for pertussis antigens.",
            "startOffset": 44885,
            "title": "Discussion"
        },
        {
            "endOffset": 42927,
            "parents": [],
            "secId": "s0070",
            "sentence": "Antibody GMCs against each pertussis antigen observed in the Co-ad group were significantly higher than the levels reported in the German trial.",
            "startOffset": 42783,
            "title": "Discussion"
        },
        {
            "endOffset": 24252,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 24251,
                    "startOffset": 24248
                }
            },
            "secId": "s0005",
            "sentence": "More than 1.2 million cases and 135,000 IMD-related deaths per year are reported worldwide [1].",
            "startOffset": 24157,
            "title": "Background"
        },
        {
            "endOffset": 27058,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, data regarding the co-administration of MenACWY-TT with both diphtheria-tetanus-pertussis-containing vaccines and HPV vaccines are not available to date.",
            "startOffset": 26896,
            "title": "Background"
        },
        {
            "endOffset": 31027,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 31026,
                    "startOffset": 31022
                }
            },
            "secId": "s0020",
            "sentence": "Antibody titres for meningococcal serogroups were determined by serum bactericidal assay using baby rabbit complement (rSBA), performed at the Public Health England laboratory [30].",
            "startOffset": 30846,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 39087,
            "parents": [],
            "secId": "s0070",
            "sentence": "This was the first study to assess co-administration of MenACWY-TT, AS04-HPV16/18 and Tdap and the first to evaluate co-administration of MenACWY-TT with AS04-HPV16/18 in female adolescents and young adults.",
            "startOffset": 38880,
            "title": "Discussion"
        },
        {
            "endOffset": 34881,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "The percentages of participants with rSBA titres \u22658 and \u2265128 against each of the four meningococcal serogroups were \u226597.3%, in the ACWY, ACWYHPV and Co-ad groups.",
            "startOffset": 34719,
            "title": "MenACWY-TT"
        },
        {
            "endOffset": 36686,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "Booster responses to pertussis antigens were observed for 89.0\u201397.2% of participants in the Co-ad and Tdap groups (Table 4).",
            "startOffset": 36562,
            "title": "Tdap"
        },
        {
            "endOffset": 34718,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "One month after MenACWY-TT vaccination, vaccine responses against all meningococcal serogroups were observed in \u226593.8%, \u226592.2% and \u226590.2% of participants in groups ACWY, ACWYHPV and Co-ad, respectively.",
            "startOffset": 34516,
            "title": "MenACWY-TT"
        },
        {
            "endOffset": 43485,
            "parents": [],
            "secId": "s0070",
            "sentence": "Our study showed that co-administration of MenACWY-TT, AS04-HPV16/18 and Tdap was well-tolerated in female adolescents and young adults.",
            "startOffset": 43349,
            "title": "Discussion"
        },
        {
            "endOffset": 46510,
            "parents": [],
            "secId": "s0085",
            "sentence": "LR, AP and PC participated in collection and interpretation of data and performed the study.",
            "startOffset": 46418,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 30766,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Immunogenicity was assessed at one month post-vaccination for MenACWY-TT and Tdap and at one month post-third dose for AS04-HPV16/18 (Fig. 1).",
            "startOffset": 30624,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 38502,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Two pregnancies were lost to follow-up and one elective and two spontaneous abortions (with no apparent congenital anomalies) were reported.",
            "startOffset": 38362,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 32732,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "New onset chronic illnesses, potential immune-mediated diseases and serious AEs (SAEs) were recorded until study end.",
            "startOffset": 32615,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 37467,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Grade 3 symptoms were rare (in \u22643.5% of participants across all study groups); all were assessed as related to vaccination (Fig. 2B).",
            "startOffset": 37334,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 43349,
            "parents": [],
            "refoffsets": {
                "b0250": {
                    "endOffset": 43103,
                    "startOffset": 43099
                }
            },
            "secId": "s0070",
            "sentence": "Since the efficacy of DTaP was previously demonstrated [49], our results suggest that Tdap co-administered with MenACWY-TT and AS04-HPV16/18 induces an immune response to pertussis in females aged 9\u201325 years consistent with protection against disease, regardless of non-inferiority criteria not being met.",
            "startOffset": 43044,
            "title": "Discussion"
        },
        {
            "endOffset": 33386,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Immunogenicity analyses were performed in two separate according-to-protocol (ATP) cohorts for immunogenicity: the MenACWY-TT/Tdap and the HPV cohorts (Fig. 1).",
            "startOffset": 33226,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 27683,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 27573,
                    "startOffset": 27569
                },
                "b0145": {
                    "endOffset": 27595,
                    "startOffset": 27591
                }
            },
            "secId": "s0005",
            "sentence": "Moreover, co-administration of MenACWY-TT [28] or AS04-HPV16/18 [29] with Tdap has already been shown to be immunogenic and safe in the targeted population.",
            "startOffset": 27527,
            "title": "Background"
        },
        {
            "endOffset": 41467,
            "parents": [],
            "secId": "s0070",
            "sentence": "Non-inferiority of Tdap co-administered with MenACWY-TT and AS04-HPV16/18 versus administration of Tdap was not concluded for the pertussis antigens.",
            "startOffset": 41318,
            "title": "Discussion"
        },
        {
            "endOffset": 28053,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, this study aimed to demonstrate the non-inferiority of antibody responses of the three vaccines co-administered versus MenACWY-TT given alone and AS04-HPV16/18 co-administered with Tdap and of MenACWY-TT co-administered with AS04-HPV16/18 versus each of the two vaccines alone, in female adolescents and young adults, regardless of their geographic location.",
            "startOffset": 27684,
            "title": "Background"
        },
        {
            "endOffset": 37585,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Overall, unsolicited AEs were similar in nature and intensity and had a comparable incidence across groups (Table S2).",
            "startOffset": 37467,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 28712,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Participants were healthy females aged 9\u201325 years, of non-child bearing potential or practicing adequate contraception (see a full list of inclusion/exclusion criteria in Supplementary Text S1).",
            "startOffset": 28518,
            "title": "Study design and participants"
        },
        {
            "endOffset": 30607,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study is registered at www.clinicaltrials.gov (NCT01755689) and a protocol summary is available at https://www.gsk-clinicalstudyregister.com/study_ids=113823.",
            "startOffset": 30445,
            "title": "Study design and participants"
        },
        {
            "endOffset": 29087,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Due to differences in the vaccines\u2019 presentation and in the number of vaccinations administered to each group, the study was open-label, but laboratory staff in charge of testing was blinded to the vaccines received.",
            "startOffset": 28871,
            "title": "Study design and participants"
        },
        {
            "endOffset": 37963,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Following the first AS04-HPV16/18 dose in the ACWY group, at least one unsolicited AE of any severity was reported for 8.5% participants and 1.2% participants reported Grade 3 unsolicited AEs (Table S2).",
            "startOffset": 37760,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 44602,
            "parents": [],
            "secId": "s0070",
            "sentence": "The results of our study can easily be generalized to Latin American, European and Asian girls and young women, but the need for vaccine co-administration should be judged by national health authorities based on the burden of diseases in each country.",
            "startOffset": 44351,
            "title": "Discussion"
        },
        {
            "endOffset": 31437,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Serum anti-HPV-16/-18 antibodies were measured at the Centre for Vaccinology Ghent, Belgium, by an enzyme-linked immunosorbent assay (ELISA), with cut-offs of 19 and 18 ELISA units (EU)/mL for anti-HPV-16 and anti-HPV-18 antibodies, respectively.",
            "startOffset": 31191,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33225,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The power to meet all primary confirmatory objectives was >92.98%, with a global type I error of 2.5% and type II error <7.02%.",
            "startOffset": 33098,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 40487,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 40486,
                    "startOffset": 40479
                },
                "b0210": {
                    "endOffset": 40486,
                    "startOffset": 40479
                }
            },
            "secId": "s0070",
            "sentence": "However, although this trend was also observed in a study in which healthy individuals received MenACWY-TT at 11\u201317 years of age [38], the long-term persistence of immune response to serogroup A was not impacted and one dose of MenACWY-TT was shown to afford protection for the majority of vaccinees up to five years post-vaccination [38,42].",
            "startOffset": 40145,
            "title": "Discussion"
        },
        {
            "endOffset": 45798,
            "parents": [],
            "secId": "s0075",
            "sentence": "The lower antibody concentrations observed against pertussis components may be of limited clinical relevance, since robust anti-pertussis booster responses were observed.",
            "startOffset": 45628,
            "title": "Conclusions"
        },
        {
            "endOffset": 24358,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 24357,
                    "startOffset": 24354
                }
            },
            "secId": "s0005",
            "sentence": "The incidence of IMD is highest in infants, but a second peak occurs in adolescents and young adults [2].",
            "startOffset": 24253,
            "title": "Background"
        },
        {
            "endOffset": 31684,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 31458,
                    "startOffset": 31454
                },
                "b0170": {
                    "endOffset": 31480,
                    "startOffset": 31476
                }
            },
            "secId": "s0020",
            "sentence": "Anti-diphtheria [33] and anti-tetanus [34] antibody levels were measured at the GSK Clinical Laboratory Sciences, Rixensart, Belgium, by an in-house ELISA, with assay cut-offs of 0.057 (diphtheria) and 0.043 international units (IU)/ml (tetanus).",
            "startOffset": 31438,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 46118,
            "parents": [],
            "secId": "s0075",
            "sentence": "Therefore, our safety and immunogenicity data support concurrent administration of MenACWY-TT, AS04-HPV16/18 and Tdap in adolescents, an age group in which vaccination coverages can be greatly improved by vaccine co-administration, as a reduced number of clinic visits may significantly increase vaccination compliance.",
            "startOffset": 45799,
            "title": "Conclusions"
        },
        {
            "endOffset": 25809,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 25739,
                    "startOffset": 25735
                },
                "b0085": {
                    "endOffset": 25808,
                    "startOffset": 25804
                }
            },
            "secId": "s0005",
            "sentence": "Persistent infection with high-risk HPV types can lead to cervical cancer [16], with types 16 and 18 accounting for approximately 70% of cases [17].",
            "startOffset": 25661,
            "title": "Background"
        },
        {
            "endOffset": 42475,
            "parents": [],
            "secId": "s0070",
            "sentence": "Taking into account the high booster response to pertussis antigens, it is unknown whether the failure to meet non-inferiority of immunogenicity in terms of GMCs affects the efficacy of immunity against pertussis disease.",
            "startOffset": 42254,
            "title": "Discussion"
        },
        {
            "endOffset": 38644,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "At least one SAE was reported by 0.8\u20132.7% of participants, none of which were assessed by the investigators as vaccination-related (Table S2).",
            "startOffset": 38502,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 45441,
            "parents": [],
            "secId": "s0070",
            "sentence": "In addition, the period of safety data collection following vaccination AS04-HPV16/18 differed between the ACWY and the other groups, due to the different timing of the first dose administered.",
            "startOffset": 45248,
            "title": "Discussion"
        },
        {
            "endOffset": 32487,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "AEs were graded by intensity by the investigators.",
            "startOffset": 32437,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 39501,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 39500,
                    "startOffset": 39493
                },
                "b0195": {
                    "endOffset": 39500,
                    "startOffset": 39493
                },
                "b0200": {
                    "endOffset": 39500,
                    "startOffset": 39493
                }
            },
            "secId": "s0070",
            "sentence": "Immune response to MenACWY-TT vaccination was robust, with \u226590.2% of all participants exhibiting a vaccine response, consistent with previous reports following administration of a single vaccine dose to adolescents and young adults [38\u201340].",
            "startOffset": 39261,
            "title": "Discussion"
        },
        {
            "endOffset": 25131,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 25130,
                    "startOffset": 25126
                }
            },
            "secId": "s0005",
            "sentence": "Therefore, adolescent vaccination against N. meningitidis is already recommended in several countries worldwide [11].",
            "startOffset": 25014,
            "title": "Background"
        },
        {
            "endOffset": 25660,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 25659,
                    "startOffset": 25655
                }
            },
            "secId": "s0005",
            "sentence": "Likewise, HPV infection, the most common viral infection of the reproductive track, shows an age-specific prevalence peak in women <25 years of age [15].",
            "startOffset": 25507,
            "title": "Background"
        },
        {
            "endOffset": 40018,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 40017,
                    "startOffset": 40013
                }
            },
            "secId": "s0070",
            "sentence": "Similarly, in a previous study in adolescents assessing non-inferiority of MenACWY-TT co-administered with Tdap versus its administration alone, lower antibody levels against all meningococcal serogroups were noted when the vaccines were co-administered, although non-inferiority criteria were met [41].",
            "startOffset": 39715,
            "title": "Discussion"
        },
        {
            "endOffset": 36950,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Pain at injection site was the most frequently reported solicited local symptom in all groups, by \u226460.0%, \u226476.6% and 74.8\u201384.7% of participants following administration of MenACWY-TT, Tdap and the first AS04-HPV16/18 dose, respectively.",
            "startOffset": 36714,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 41916,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 41915,
                    "startOffset": 41911
                }
            },
            "secId": "s0070",
            "sentence": "Suppression of response to pertussis in terms of GMCs was also observed to some extent when Tdap was co-administered with a meningococcal CRM197-conjugated vaccine and a quadrivalent HPV vaccine in adolescents 11\u201318 years of age [44].",
            "startOffset": 41682,
            "title": "Discussion"
        },
        {
            "endOffset": 34205,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Demographic characteristics were balanced between groups (Supplementary Table S1).",
            "startOffset": 34123,
            "title": "Demographics"
        },
        {
            "endOffset": 25013,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 25012,
                    "startOffset": 25006
                },
                "b0050": {
                    "endOffset": 25012,
                    "startOffset": 25006
                }
            },
            "secId": "s0005",
            "sentence": "Vaccination in adolescence not only affords direct protection against meningococcal disease, but also reduces carriage, thus maintaining a herd effect shown to be important even in other age groups [9,10].",
            "startOffset": 24808,
            "title": "Background"
        },
        {
            "endOffset": 26895,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 26835,
                    "startOffset": 26831
                },
                "b0120": {
                    "endOffset": 26894,
                    "startOffset": 26890
                }
            },
            "secId": "s0005",
            "sentence": "The quadrivalent meningococcal vaccine including capsular polysaccharides of serogroups A, C, W and Y conjugated to tetanus toxoid (TT) (MenACWY-TT; Nimenrix, Pfizer) is currently approved for worldwide use in adolescents [23] and has shown good immunogenicity and safety profiles [24].",
            "startOffset": 26609,
            "title": "Background"
        },
        {
            "endOffset": 29660,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki.",
            "startOffset": 29551,
            "title": "Study design and participants"
        },
        {
            "endOffset": 38181,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "From first dose up to study end, at least one new onset chronic illnesses was reported by no more than three (1.2%) individuals in each study group, and no non-serious potential immune-mediated diseases were reported.",
            "startOffset": 37964,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 43754,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 43753,
                    "startOffset": 43749
                },
                "b0145": {
                    "endOffset": 43693,
                    "startOffset": 43689
                }
            },
            "secId": "s0070",
            "sentence": "The respective reactogenicity and safety profiles were not affected by their co-administration and remained similar across groups, as previously reported for co-administration of AS04-HPV16/18 with Tdap [29] or MenACWY-TT and combination vaccines containing Tdap [28].",
            "startOffset": 43486,
            "title": "Discussion"
        },
        {
            "endOffset": 46719,
            "parents": [],
            "secId": "s0085",
            "sentence": "PVS and AJ participated in the analyses and interpretation of data, MW participated in the conception, design and planning of the study, supervised the analysis, participated in the interpretation of results.",
            "startOffset": 46511,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 47134,
            "parents": [],
            "secId": "s0090",
            "sentence": "GlaxoSmithKline Biologicals SA also took in charge all costs associated to the development and publishing of the present manuscript.",
            "startOffset": 47002,
            "title": "Funding"
        },
        {
            "endOffset": 36333,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "However, for tetanus, significantly higher (based on non-overlapping 95% CIs) antibody GMCs were observed in the ACWY and Co-ad group compared with the Tdap group (Table 4).",
            "startOffset": 36160,
            "title": "Tdap"
        },
        {
            "endOffset": 42253,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 42252,
                    "startOffset": 42248
                }
            },
            "secId": "s0070",
            "sentence": "Moreover, high booster responses to pertussis antigens were shown in our study and they were previously employed to evaluate non-inferiority of sequential Tdap/meningococcal vaccinations versus co-administration [45].",
            "startOffset": 42036,
            "title": "Discussion"
        },
        {
            "endOffset": 45131,
            "parents": [],
            "secId": "s0070",
            "sentence": "In the absence of correlates of protection for pertussis, booster responses may better reflect the actual immune responses in adolescents.",
            "startOffset": 44993,
            "title": "Discussion"
        },
        {
            "endOffset": 46217,
            "parents": [],
            "secId": "s0080",
            "sentence": "Nimenrix is a trademark owned by the GSK group of companies, licensed to Pfizer.",
            "startOffset": 46137,
            "title": "Trademark statement"
        },
        {
            "endOffset": 29436,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The six co-primary, confirmatory objectives of the study and the statistical criteria used are summarized in Table 1.",
            "startOffset": 29319,
            "title": "Study design and participants"
        },
        {
            "endOffset": 26609,
            "parents": [],
            "secId": "s0005",
            "sentence": "Therefore, vaccine co-administration resulting in a reduced number of clinic visits may improve the implementation and achievable coverage of adolescent vaccination programs.",
            "startOffset": 26435,
            "title": "Background"
        },
        {
            "endOffset": 34516,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "Non-inferiority of MenACWY-TT co-administered with AS04-HPV16/18 or with AS04-HPV16/18 and Tdap compared to MenACWY-TT alone was demonstrated, as the pre-established non-inferiority criteria were met (Table 1).",
            "startOffset": 34306,
            "title": "MenACWY-TT"
        },
        {
            "endOffset": 34291,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The first five co-primary objectives of the study were met (Table 1).",
            "startOffset": 34222,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 24156,
            "parents": [],
            "secId": "s0005",
            "sentence": "Invasive meningococcal disease (IMD) is a serious bacterial infection that coincides with a high burden of disease in endemic areas.",
            "startOffset": 24024,
            "title": "Background"
        },
        {
            "endOffset": 44217,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 44216,
                    "startOffset": 44212
                }
            },
            "secId": "s0070",
            "sentence": "Estonia also recommends Tdap vaccination in the same age group [11].",
            "startOffset": 44149,
            "title": "Discussion"
        },
        {
            "endOffset": 32614,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All solicited local symptoms were considered related to vaccination; investigators assessed the causality of all other events.",
            "startOffset": 32488,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 35047,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "Trends for higher post-vaccination GMTs in the ACWYHPV group and lower GMTs in the Co-ad group compared to the ACWY group were observed for all serogroups (Table 2).",
            "startOffset": 34882,
            "title": "MenACWY-TT"
        },
        {
            "endOffset": 38869,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "For one (0.4%) infant born following a pregnancy in the Tdap group, three SAEs (prematurity, low weight at birth and respiratory distress syndrome) were reported, with fatal outcome, but were not assessed as vaccine-related.",
            "startOffset": 38645,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 25506,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 25383,
                    "startOffset": 25379
                },
                "b0065": {
                    "endOffset": 25505,
                    "startOffset": 25498
                },
                "b0070": {
                    "endOffset": 25505,
                    "startOffset": 25498
                }
            },
            "secId": "s0005",
            "sentence": "Periodic resurgences of pertussis were recorded every 3\u20135 years [12] even in industrialized countries with high immunization rates, with increased incidence in adolescents and adults [13,14].",
            "startOffset": 25315,
            "title": "Background"
        },
        {
            "endOffset": 46301,
            "parents": [],
            "secId": "s0080",
            "sentence": "Cervarix, Boostrix and Infanrix are trademarks owned by the GSK group of companies.",
            "startOffset": 46218,
            "title": "Trademark statement"
        },
        {
            "endOffset": 39260,
            "parents": [],
            "secId": "s0070",
            "sentence": "Non-inferiority of MenACWY-TT immunogenicity when co-administered with either AS04-HPV16/18 or with AS04-HPV16/18 and Tdap was demonstrated for all meningococcal serogroups.",
            "startOffset": 39087,
            "title": "Discussion"
        },
        {
            "endOffset": 26218,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 26142,
                    "startOffset": 26138
                }
            },
            "secId": "s0005",
            "sentence": "Immunizations against diphtheria, tetanus and pertussis (as a booster dose) and against HPV (primarily in females, as two- or three-dose schedules) are also recommended by the World Health Organization during adolescence [19] and most countries worldwide implemented their use in vaccination programs.",
            "startOffset": 25917,
            "title": "Background"
        },
        {
            "endOffset": 30385,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "These participants were eliminated from the analyses of immunogenicity for the relevant time points, but were followed for safety and pregnancy outcomes throughout the study.",
            "startOffset": 30211,
            "title": "Study design and participants"
        },
        {
            "endOffset": 24496,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 24495,
                    "startOffset": 24490
                },
                "b0015": {
                    "endOffset": 24495,
                    "startOffset": 24490
                }
            },
            "secId": "s0005",
            "sentence": "Six Neisseria meningitidis serogroups (A, B, C, W, Y, X) account for virtually all IMD, and their prevalence varies geographically [1,3].",
            "startOffset": 24359,
            "title": "Background"
        },
        {
            "endOffset": 37236,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Fatigue, headache and myalgia were the most frequently reported solicited general symptoms, by 32.0\u201342.3% of participants in all groups.",
            "startOffset": 37100,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 47001,
            "parents": [],
            "secId": "s0090",
            "sentence": "The work was supported by GlaxoSmithKline Biologicals SA, which was involved in all stages of the study conduct and analysis as well as the development of the manuscript and its approval for submission.",
            "startOffset": 46799,
            "title": "Funding"
        },
        {
            "endOffset": 37333,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Solicited general symptoms were considered as related to vaccination for \u226439.6% of participants.",
            "startOffset": 37237,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 27414,
            "parents": [],
            "secId": "s0005",
            "sentence": "The current study assessed the immunogenicity of MenACWY-TT and the HPV 16/18 AS04-adjuvanted vaccine (AS04-HPV16/18; Cervarix, GSK) when administered together and when given with a tetanus-diphtheria-acellular pertussis vaccine (Tdap; Boostrix, GSK) in female adolescents and young adults aged 9\u201325 years from the Dominican Republic, Estonia and Thailand.",
            "startOffset": 27058,
            "title": "Background"
        },
        {
            "endOffset": 30210,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Protocol deviations related to inadequate contraception methods were reported by 24 vaccinated participants, leading to 21 pregnancies.",
            "startOffset": 30075,
            "title": "Study design and participants"
        },
        {
            "endOffset": 43043,
            "parents": [],
            "secId": "s0070",
            "sentence": "Moreover, antibody GMCs for pertussis components increased \u226510-fold from pre-vaccination levels in the Co-ad group.",
            "startOffset": 42928,
            "title": "Discussion"
        },
        {
            "endOffset": 45627,
            "parents": [],
            "secId": "s0075",
            "sentence": "This study showed that immune responses to MenACWY-TT, AS04-HPV16/18 and diphtheria and tetanus antigens from Tdap were not impacted by the co-administration of the vaccines.",
            "startOffset": 45453,
            "title": "Conclusions"
        },
        {
            "endOffset": 24701,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 24634,
                    "startOffset": 24631
                },
                "b0025": {
                    "endOffset": 24671,
                    "startOffset": 24666
                },
                "b0030": {
                    "endOffset": 24671,
                    "startOffset": 24666
                },
                "b0035": {
                    "endOffset": 24681,
                    "startOffset": 24678
                }
            },
            "secId": "s0005",
            "sentence": "In Europe and Latin America, predominant serogroups are B and C, while in Asia, A and C are the most prevalent serogroups causing IMD [4], although lately, serogroups Y [5,6] and W [7] have been emerging.",
            "startOffset": 24497,
            "title": "Background"
        },
        {
            "endOffset": 24807,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 24806,
                    "startOffset": 24803
                }
            },
            "secId": "s0005",
            "sentence": "Meningococcal carriage is low in infants, but increases during childhood and peaks in 12\u201319-year-olds [8].",
            "startOffset": 24701,
            "title": "Background"
        },
        {
            "endOffset": 29551,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Secondary objectives included the evaluation of immune responses to the study vaccines, safety and reactogenicity.",
            "startOffset": 29437,
            "title": "Study design and participants"
        },
        {
            "endOffset": 42035,
            "parents": [],
            "secId": "s0070",
            "sentence": "Nevertheless, in the absence of correlate of protection for pertussis, the relevance of these findings may be limited.",
            "startOffset": 41917,
            "title": "Discussion"
        },
        {
            "endOffset": 41317,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 41205,
                    "startOffset": 41201
                },
                "b0220": {
                    "endOffset": 41316,
                    "startOffset": 41312
                }
            },
            "secId": "s0070",
            "sentence": "These results are consistent with recent reports in 11\u201325-year-old individuals evaluating co-administration of MenACWY-TT and Tdap [41] and can be explained by an enhanced immune response to tetanus by the TT-conjugated meningococcal vaccine [43].",
            "startOffset": 41070,
            "title": "Discussion"
        },
        {
            "endOffset": 26434,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 26344,
                    "startOffset": 26340
                },
                "b0105": {
                    "endOffset": 26433,
                    "startOffset": 26426
                },
                "b0110": {
                    "endOffset": 26433,
                    "startOffset": 26426
                }
            },
            "secId": "s0005",
            "sentence": "However, adherence to current recommendations and vaccination schedules among adolescents and young adults is problematic [20], especially for the multi-dose schedules needed to afford protection against HPV [21,22].",
            "startOffset": 26218,
            "title": "Background"
        },
        {
            "endOffset": 36159,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "One month after Tdap vaccination, seroprotective levels were observed in all participants in the Co-ad and Tdap group for diphtheria and tetanus, with lower antibody GMCs values observed in the Co-ad group compared to the Tdap group for diphtheria.",
            "startOffset": 35911,
            "title": "Tdap"
        },
        {
            "endOffset": 44350,
            "parents": [],
            "secId": "s0070",
            "sentence": "Therefore, all these countries could benefit from a vaccination schedule using co-administration of all three vaccines in one visit.",
            "startOffset": 44218,
            "title": "Discussion"
        },
        {
            "endOffset": 32877,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Pregnancies and their outcomes were described in detail.",
            "startOffset": 32821,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 28517,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Enrolled participants were randomized (1:1:1:1:1) into one of five groups (ACWY, ACWYHPV, HPV, Co-ad and Tdap), receiving MenACWY-TT and/or Tdap and/or AS04-HPV16/18, co-administered or alone, according to different schedules over a period of maximum seven months (Fig. 1).",
            "startOffset": 28244,
            "title": "Study design and participants"
        },
        {
            "endOffset": 31190,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 31143,
                    "startOffset": 31139
                },
                "b0155": {
                    "endOffset": 31188,
                    "startOffset": 31181
                },
                "b0160": {
                    "endOffset": 31188,
                    "startOffset": 31181
                }
            },
            "secId": "s0020",
            "sentence": "An rSBA titre of eight was used as serological correlate of protection (previously established for serogroup C [30] and extended to the other serogroups [31,32]).",
            "startOffset": 31028,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 34122,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Of 1300 vaccinated participants, 1274 completed the study; none of the withdrawals were due to an AE (Fig. 1).",
            "startOffset": 34012,
            "title": "Demographics"
        },
        {
            "endOffset": 41069,
            "parents": [],
            "secId": "s0070",
            "sentence": "Of note, immune responses to tetanus were significantly higher in the group receiving MenACWY-TT co-administered with Tdap than after one dose of Tdap alone.",
            "startOffset": 40912,
            "title": "Discussion"
        },
        {
            "endOffset": 30074,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study protocol and informed consent/assent forms were reviewed and approved by an Independent Ethics Committee or Institutional Review Board at each centre.",
            "startOffset": 29914,
            "title": "Study design and participants"
        },
        {
            "endOffset": 25314,
            "parents": [],
            "secId": "s0005",
            "sentence": "Besides N. meningitidis, Bordetella pertussis and human papillomavirus (HPV) are important disease-causing pathogens, with a high risk of transmission in adolescents and young adults.",
            "startOffset": 25131,
            "title": "Background"
        },
        {
            "endOffset": 27526,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 27525,
                    "startOffset": 27518
                },
                "b0130": {
                    "endOffset": 27525,
                    "startOffset": 27518
                },
                "b0135": {
                    "endOffset": 27525,
                    "startOffset": 27518
                }
            },
            "secId": "s0005",
            "sentence": "The immunogenicity and tolerability of each of the three vaccines is well documented in this age group [25\u201327].",
            "startOffset": 27415,
            "title": "Background"
        },
        {
            "endOffset": 35612,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0055",
            "sentence": "GMC values ranged from 9563.8 (Co-ad) to 12124.9 (ACWYHPV) and from 4306.2 (Co-ad) to 5655.0 (HPV) in all study groups, for anti-HPV-16 and anti-HPV-18 antibodies, respectively (Table 3).",
            "startOffset": 35425,
            "title": "AS04-HPV16/18"
        },
        {
            "endOffset": 28870,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Randomization was performed with an internet-based system, using a minimization procedure accounting for age strata (9\u201314, 15\u201317 and 18\u201325 years) and centre.",
            "startOffset": 28713,
            "title": "Study design and participants"
        },
        {
            "endOffset": 33989,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All analyses were performed using SAS.",
            "startOffset": 33951,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 28243,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This phase III, open, controlled study was conducted between January 2013 and April 2014 in 3 centres in Estonia, Thailand and the Dominican Republic.",
            "startOffset": 28093,
            "title": "Study design and participants"
        },
        {
            "endOffset": 44148,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, HPV vaccination is implemented in the Dominican Republic (in girls 9\u201310 years at first vaccination) and Estonia (in adolescents aged 15\u201316 years) nationwide, and as a pilot program in a region of Thailand (in 11-year-old girls).",
            "startOffset": 43911,
            "title": "Discussion"
        },
        {
            "endOffset": 41681,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 41680,
                    "startOffset": 41676
                }
            },
            "secId": "s0070",
            "sentence": "Similarly, in a recent study, non-inferiority of Tdap immunogenicity when co-administered with MenACWY-TT versus its separate administration was not demonstrated for pertussis antigens in terms of GMC ratios [41].",
            "startOffset": 41468,
            "title": "Discussion"
        },
        {
            "endOffset": 33602,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Geometric mean titres/concentrations (GMTs/GMCs) and the percentage of participants with antibody titres/concentrations above pre-specified thresholds were computed with 95% confidence intervals (CIs) for each group.",
            "startOffset": 33386,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 45247,
            "parents": [],
            "secId": "s0070",
            "sentence": "AEs were only assessed following the first dose of each vaccine, and this constitutes another potential limitation.",
            "startOffset": 45132,
            "title": "Discussion"
        },
        {
            "endOffset": 32820,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Occurrences of Guillain-Barr\u00e9 syndrome and meningococcal disease were reported as SAEs.",
            "startOffset": 32733,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 40911,
            "parents": [],
            "secId": "s0070",
            "sentence": "Non-inferiority of Tdap co-administered with MenACWY-TT and AS04-HPV16/18 versus administration of Tdap and AS04-HPV16/18 was demonstrated for diphtheria and tetanus.",
            "startOffset": 40745,
            "title": "Discussion"
        },
        {
            "endOffset": 25916,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 25915,
                    "startOffset": 25911
                }
            },
            "secId": "s0005",
            "sentence": "In 2012, an estimated 527,600 new cases and 265,700 deaths due to cervical cancer occurred worldwide [18].",
            "startOffset": 25810,
            "title": "Background"
        },
        {
            "endOffset": 30444,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All protocol deviations were reported to Ethic Committees.",
            "startOffset": 30386,
            "title": "Study design and participants"
        },
        {
            "endOffset": 33097,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "A target sample size of 1300 enrolled participants (260 per group) was calculated to ensure 225 evaluable participants per group for immunogenicity analyses, when considering a dropout-rate of 15%.",
            "startOffset": 32900,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 33951,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Safety analyses were conducted in the total vaccinated cohort, which included all participants with documented vaccine administration.",
            "startOffset": 33817,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 37759,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Following first vaccination, at least one unsolicited AE was reported by 13.4\u201316.2% of participants in all groups; \u22641.9% of all participants reported Grade 3 AEs (Table S2).",
            "startOffset": 37586,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 32188,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "In the absence of an established correlate of protection, the assay cut-offs were used as seropositivity thresholds.",
            "startOffset": 32072,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32436,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Solicited local and general symptoms were reported during days 0\u20136 and unsolicited adverse events (AEs) during days 0\u201330 following administration of MenACWY-TT and Tdap and the first dose of AS04-HPV16/18 by diary cards.",
            "startOffset": 32216,
            "title": "Safety and reactogenicity"
        },
        {
            "endOffset": 31812,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 31754,
                    "startOffset": 31750
                }
            },
            "secId": "s0020",
            "sentence": "The clinical threshold of 0.1 IU/mL was considered as protective [35]; the1.0 IU/mL cut-off was used for confirmatory analysis.",
            "startOffset": 31685,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 46792,
            "parents": [],
            "secId": "s0085",
            "sentence": "All authors participated in the drafting and approval of the manuscript.",
            "startOffset": 46720,
            "title": "Authors\u2019 contribution"
        },
        {
            "endOffset": 29319,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Tdap was administered in the lower left (Co-ad group) or right (Tdap group) deltoid.",
            "startOffset": 29235,
            "title": "Study design and participants"
        },
        {
            "endOffset": 42782,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 42673,
                    "startOffset": 42669
                },
                "b0240": {
                    "endOffset": 42781,
                    "startOffset": 42774
                },
                "b0245": {
                    "endOffset": 42781,
                    "startOffset": 42774
                }
            },
            "secId": "s0070",
            "sentence": "Antibody levels induced by three doses of a combined diphtheria-tetanus-acellular pertussis vaccine (DTaP; Infanrix, GSK) in infancy, as reported from a German household contact efficacy trial [46] were also previously used as comparison for the evaluation of immune response to pertussis antigens [47,48].",
            "startOffset": 42476,
            "title": "Discussion"
        },
        {
            "endOffset": 29790,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Written informed consent was obtained from each participant of legal age or the participant\u2019s parent/guardian prior to enrolment.",
            "startOffset": 29661,
            "title": "Study design and participants"
        }
    ],
    "docId": "S0264410X18306716",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "lrp@claro.net.do",
                "first": "Luis",
                "initial": "L.",
                "last": "Rivera"
            },
            {
                "email": "pornthep.cha@mahidol.ac.th",
                "first": "Pornthep",
                "initial": "P.",
                "last": "Chanthavanich"
            },
            {
                "email": "airi.poder@std.ee",
                "first": "Airi",
                "initial": "A.",
                "last": "P\u00f5der"
            },
            {
                "email": "p.v.suryakiran@gsk.com",
                "first": "P. V.",
                "initial": "P.V.",
                "last": "Suryakiran"
            },
            {
                "email": "archana.m.jastorff@gsk.com",
                "first": "Archana",
                "initial": "A.",
                "last": "Jastorff"
            },
            {
                "email": "marie.x.van-der-wielen@gsk.com",
                "first": "Marie",
                "initial": "M.",
                "last": "Van der Wielen"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.05.051",
        "firstpage": "3967",
        "issn": "0264410X",
        "keywords": [
            "Adolescent vaccination",
            "Co-administration",
            "Diphtheria-tetanus-acellular pertussis vaccine",
            "HPV 16/18 AS04-adjuvanted vaccine",
            "Quadrivalent meningococcal conjugate vaccine"
        ],
        "lastpage": "3975",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial"
    }
}